Epithelial to mesenchymal: Difference between revisions
From FANTOM5_SSTAR
m (Autoedit moved page TimeCourse:human ARPE 19 to ARPE 19 without leaving a redirect: NSchange) |
No edit summary |
||
Line 8: | Line 8: | ||
|species=Human (Homo sapiens) | |species=Human (Homo sapiens) | ||
|zenbu_config=http://fantom.gsc.riken.jp/zenbu/gLyphs/#config=6MLr303UKRFjRf00h2lL_D | |zenbu_config=http://fantom.gsc.riken.jp/zenbu/gLyphs/#config=6MLr303UKRFjRf00h2lL_D | ||
|TCOverview=Epithelial–mesenchymal transition (EMT) is a process of transition from epithelial cells to mesenchymal cells characterized by loss of cell adhesion and polarity, repression of E-cadherin expression, gain of cell motility and nvasive properties. EMT is essential for numerous developmental processes including mesoderm formation and neural tube formation. EMT is also essential for wound healing, organ fibrosis and initiation of metastasis for cancer progression. During the process of epithelial to mesenchymal transition, epithelial cells transforms to mesenchymal cells, and change their shapes. Mesenchymal cells get to gather and form focus. To clarify the transcriptional networks regulating EMT, we obtained time-course sample of human ARPE-19 epithelial to mesenchymal transition. After preculture for 7 days on 10cm dishes and cell seeding and cell culture for 5 days on 6-well glass bottom plate, we induced epithelial to mesenchymal transition on human ARPE-19 cells by TT-mixture of TNFα and TGFβ2. Triplication for RNA extraction and 1 for imaging. We sampled total RNA of human ARPE-19 cells along with time-course of epithelial to mesenchymal transition. | |||
|TCSample_description=ARPE-19 cells were cultured in Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 medium (Sigma-Aldrich) with 10% fetal bovine serum in a CO2 incubator at 37 °C. After 5 days of preculture, cells were treated with human recombinant TGF-β2 and human recombinant TNF-α and continuously incubated in serum free medium at 37 °C to induce EMT. At 21 different time points (0 min, 15 min, 30 min, 45 min, 60 min, 80 min, 100 min, 2 hr, 2.5 hr, 3 hr, 3.5 hr, 4 hr, 5 hr, 6 hr, 7 hr, 8 hr, 12 hr, 16 hr, 24 hr, 42 hr and 60 hr), cells were dissolved in lysis reagent and collected. For the samples of 0 min, cells were treated with PBS without TGF-β2 and TNF-α. Using miRNeasy Mini Kit (QIAGEN), total RNA was extracted from each cell lysate according to a manufacturer’s protocol.<br> | |||
<html><img src='https://fantom5-collaboration.gsc.riken.jp/resource_browser/images/TC_qc/800px-Human_ARPE-19_sample_protocols.png' width='700px'/></html><br> | |||
Figure 1: Sample protocol<br> | |||
<br> | |||
<html><img src='https://fantom5-collaboration.gsc.riken.jp/resource_browser/images/TC_qc/600px-Human_ARPE-19_sample_photos.png'></html><br> | |||
Figure 2: Cell morphology<br> | |||
<br> | |||
|TCQuality_control=<html><img src='https://fantom5-collaboration.gsc.riken.jp/resource_browser/images/TC_qc/1000px-Human_ARPE-19.png' onclick='javascript:window.open("https://fantom5-collaboration.gsc.riken.jp/resource_browser/images/TC_qc/1000px-Human_ARPE-19.png", "imgwindow", "width=1000,height=375");' style='width:700px;cursor:pointer'/></html><br> | |||
Figure 3: CAGE expression of marker genes in TPM. | |||
<br> | |||
}} | }} |
Revision as of 14:14, 9 December 2014
Series: | IN_VITRO DIFFERENTIATION SERIES |
---|---|
Species: | Human (Homo sapiens) |
Genomic View: | Zenbu |
Expression table: | [{{{tet_config}}} FILE] |
Link to TET: | [{{{tet_file}}} TET] |
Sample providers : | Soichi Ogishima |
Germ layer: | {{{germ_layer}}} |
Primary cells or cell line: | {{{primary_cells}}} |
Time span: | {{{time_span}}} |
Number of time points: | {{{number_time_points}}} |
Overview |
---|
Epithelial–mesenchymal transition (EMT) is a process of transition from epithelial cells to mesenchymal cells characterized by loss of cell adhesion and polarity, repression of E-cadherin expression, gain of cell motility and nvasive properties. EMT is essential for numerous developmental processes including mesoderm formation and neural tube formation. EMT is also essential for wound healing, organ fibrosis and initiation of metastasis for cancer progression. During the process of epithelial to mesenchymal transition, epithelial cells transforms to mesenchymal cells, and change their shapes. Mesenchymal cells get to gather and form focus. To clarify the transcriptional networks regulating EMT, we obtained time-course sample of human ARPE-19 epithelial to mesenchymal transition. After preculture for 7 days on 10cm dishes and cell seeding and cell culture for 5 days on 6-well glass bottom plate, we induced epithelial to mesenchymal transition on human ARPE-19 cells by TT-mixture of TNFα and TGFβ2. Triplication for RNA extraction and 1 for imaging. We sampled total RNA of human ARPE-19 cells along with time-course of epithelial to mesenchymal transition. |
Sample description |
---|
ARPE-19 cells were cultured in Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 medium (Sigma-Aldrich) with 10% fetal bovine serum in a CO2 incubator at 37 °C. After 5 days of preculture, cells were treated with human recombinant TGF-β2 and human recombinant TNF-α and continuously incubated in serum free medium at 37 °C to induce EMT. At 21 different time points (0 min, 15 min, 30 min, 45 min, 60 min, 80 min, 100 min, 2 hr, 2.5 hr, 3 hr, 3.5 hr, 4 hr, 5 hr, 6 hr, 7 hr, 8 hr, 12 hr, 16 hr, 24 hr, 42 hr and 60 hr), cells were dissolved in lysis reagent and collected. For the samples of 0 min, cells were treated with PBS without TGF-β2 and TNF-α. Using miRNeasy Mini Kit (QIAGEN), total RNA was extracted from each cell lysate according to a manufacturer’s protocol. |
Quality control |
---|
|
Profiled time course samples
Only samples that passed quality controls (Arner et al. 2015) are shown here. The entire set of samples are downloadable from FANTOM5 human / mouse samples
13625-146H7 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 00hr00min | biol_rep1 |
13626-146H8 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 00hr00min | biol_rep2 |
13627-146H9 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 00hr00min | biol_rep3 |
13628-146I1 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 00hr15min | biol_rep1 |
13629-146I2 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 00hr15min | biol_rep2 |
13630-146I3 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 00hr15min | biol_rep3 |
13631-146I4 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 00hr30min | biol_rep1 |
13632-146I5 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 00hr30min | biol_rep2 |
13633-146I6 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 00hr30min | biol_rep3 |
13634-146I7 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 00hr45min | biol_rep1 |
13635-146I8 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 00hr45min | biol_rep2 |
13636-146I9 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 00hr45min | biol_rep3 |
13637-147A1 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 01hr00min | biol_rep1 |
13638-147A2 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 01hr00min | biol_rep2 |
13639-147A3 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 01hr00min | biol_rep3 |
13640-147A4 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 01hr20min | biol_rep1 |
13641-147A5 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 01hr20min | biol_rep2 |
13642-147A6 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 01hr20min | biol_rep3 |
13643-147A7 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 01hr40min | biol_rep1 |
13644-147A8 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 01hr40min | biol_rep2 |
13645-147A9 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 01hr40min | biol_rep3 |
13646-147B1 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 02hr00min | biol_rep1 |
13647-147B2 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 02hr00min | biol_rep2 |
13648-147B3 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 02hr00min | biol_rep3 |
13649-147B4 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 02hr30min | biol_rep1 |
13650-147B5 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 02hr30min | biol_rep2 |
13651-147B6 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 02hr30min | biol_rep3 |
13652-147B7 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 03hr00min | biol_rep1 |
13653-147B8 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 03hr00min | biol_rep2 |
13654-147B9 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 03hr00min | biol_rep3 |
13655-147C1 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 03hr30min | biol_rep1 |
13656-147C2 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 03hr30min | biol_rep2 |
13657-147C3 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 03hr30min | biol_rep3 |
13658-147C4 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 04hr00min | biol_rep1 |
13659-147C5 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 04hr00min | biol_rep2 |
13660-147C6 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 04hr00min | biol_rep3 |
13661-147C7 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 05hr00min | biol_rep1 |
13662-147C8 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 05hr00min | biol_rep2 |
13663-147C9 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 05hr00min | biol_rep3 |
13664-147D1 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 06hr00min | biol_rep1 |
13666-147D3 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 06hr00min | biol_rep3 |
13667-147D4 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 07hr00min | biol_rep1 |
13668-147D5 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 07hr00min | biol_rep2 |
13669-147D6 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 07hr00min | biol_rep3 |
13670-147D7 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 08hr00min | biol_rep1 |
13671-147D8 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 08hr00min | biol_rep2 |
13672-147D9 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 08hr00min | biol_rep3 |
13674-147E2 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 12hr00min | biol_rep2 |
13675-147E3 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 12hr00min | biol_rep3 |
13676-147E4 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 16hr00min | biol_rep1 |
13677-147E5 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 16hr00min | biol_rep2 |
13678-147E6 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 16hr00min | biol_rep3 |
13679-147E7 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 24hr00min | biol_rep1 |
13681-147E9 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 24hr00min | biol_rep3 |
13682-147F1 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 42hr00min | biol_rep1 |
13683-147F2 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 42hr00min | biol_rep2 |
13684-147F3 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 42hr00min | biol_rep3 |
13685-147F4 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 60hr00min | biol_rep1 |
13686-147F5 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 60hr00min | biol_rep2 |
13687-147F6 | ARPE-19 EMT induced with TGF-beta and TNF-alpha | 60hr00min | biol_rep3 |